Skip to content

Home-Based Exercise and Weight Control Program for Pain Control in Overweight Elderly With Osteoarthritis of the Knee

Home-Based Exercise and Weight Control Program for Pain Control in Overweight Elderly With Osteoarthritis of the Knee

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00126737
Enrollment
110
Registered
2005-08-04
Start date
2002-10-31
Completion date
2008-12-31
Last updated
2015-01-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Diseases, Obesity, Osteoarthritis, Pain

Keywords

Elderly, Exercise, lean body mass, muscle strength, Nutrition program, Pain control, stair climb, walking distance, weight loss

Brief summary

The purpose of this study is to determine whether a home-based exercise and weight control program applied to elderly overweight individuals with painful osteoarthritis of the knee, would result in pain reduction.

Detailed description

Osteoarthritis (OA) is the most common chronic disease in the United States (U.S.). Arthritis is a leading chronic illness among older adults in the U.S. Approximately 40% of individuals above 60 yr of age have OA of the knee. The primary objective of the proposed study is to determine whether individuals who are overweight with OA of the knee and who complete a 24-week home-based exercise program combined with a weight control intervention program will report significantly less pain (as measured by the WOMAC) than volunteers who participate in home-based exercise (Ex) only, weight control intervention (WC) only, or standard clinical care (C). The secondary objectives of the proposed research are to determine whether overweight individuals with OA of the knee who complete the Ex+WC program, when compared to subjects who are randomly assigned to a E, WC or C groups, demonstrate significant improvement in the following health risk profile variables: (a) improved physical function (measured by the Functional Performance Inventory), (b) improved capacity to perform stair climbing and descending, (c) improved strength, (d) increased lean body mass, (e) increase in physical activity at home (measured by pedometer step count). The proposed clinical trial will utilize a prospective, randomized two by two factorial design. Descriptive and ancova statistical method will be applied for data analyses.

Interventions

OTHERWeight Control Nutritional Program

a week of food diary and information about dietary fat intake and proper proportions of vegetables.

24 week home-based exercise program encompassed aerobic exercises, isometric and isotonic exercises, and stretching exercises.

Sponsors

US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male & female 50 years old * Diagnosis of osteoarthritis by American College of Rheumatology criteria * Knee radiographs of Kellgren and Lawrence grade 2-4 * American Arthritis Association functional class 1-3 * Body mass index of 27

Exclusion criteria

* Knee arthritis which did not meet American College of Rheumatology (ACR) OA criteria * Unable to engage in exercise or follow instruction * Limited shoulder range of motion

Design outcomes

Primary

MeasureTime frameDescription
WOMAC FunctionBetween Base-line and 24 weeksWestern Ontario and McMaster University Osteoarthritis Index (WOMAC) is used to measure pain, function, and stiffness in patients with OA of the knee. At 24 weeks post-baseline, the average change in score was measured. We used the Function Scale only for this study. The Function Scale has 17 items, the responses are in Likert scale; namely 0=No difficulty, 1=Slight, 2=Moderate, 3= Very, 4=Extremely. The total score ranges from 0 to 68, a higher score means worse functioning. A score of 68 indicates extremely difficult in functioning.
Physical Scale SF-36vBetween Base-line and 24 weeksThe Rand Short Form-36 (SF-36) was used to measure health related quality of life (i.e. physical health). The average change in score 24 weeks post-baseline was measured. Physical Health consists of 4 scales, Physical Function (10 items), Role Physical (4 items), Bodily Pain (2 items), General Health (5 items). The Physical Health component is a summary measure of scales, and the scores ranges from 0 to 100, a score of 50 is the normative average of general health. Lower scores correspond to worse physical health, higher scores correspond to better physical health.
Mental Scale SF-36vBetween Base-line and 24 weeksThe Rand Short Form-36 (SF-36) was used to measure health related quality of life (i.e. mental health). The average change in score 24 weeks post-baseline was measured. Mental Health component consisted of 4 scales; these are the scales: Vitality ( 4 items), Social functioning (2 items), Role Emotional (3 items), and Mental Health (5 items). The mental health summary measures is called the Mental health component of SF36v. It was used to measure health related quality of life (i.e. mental health). The total score ranged from 0 to 100, a score of 50 is the normative average for general mental health. Lower scores correspond to worse mental health status, higher scores correspond to better mental health status.

Secondary

MeasureTime frameDescription
Walking DistanceBetween Base-line and 24 weeksAverage distance walked in six minutes. The average change in distance walked (meters) 24 weeks post-baseline was measured.
Stair Total (Climb, Descend)Between Base-line and 24 WeeksTotal amount of stairs climbed and descended for three minutes. Subjects climbed four steps up and descended four steps down. The average change in total number of steps 24 weeks post-baseline was measured.

Countries

United States

Participant flow

Recruitment details

The study sample was recruited from the general medicine and arthritis clinics of VA Hospital Hines, Illinois, and several non-VA affiliated community-based clinics.

Pre-assignment details

143 subjects were screened for eligibility in the study. 33 subjects were excluded; reasons for exclusion: 7 = cardiovascular (CV) , 3 = hospitalized, 1= knee surgery, 6 = no transport, 5 = impaired cognition, 4 = spouse illness, 4= moved, and 3 = disagree with assignment/not interested. 110 subjects were then randomized.

Participants by arm

ArmCount
Weight Control Nutritional and Home-based Exercise Pro
Group assigned to both a Weight Control Nutritional Program and home-based exercise Program (Ex+WC). Weight Control Nutritional Program: a week of food diary and information about dietary fat intake and proper proportions of vegetables Home-based exercise program: 24 week home-based exercise program encompassed aerobic exercises, isometric and isotonic exercises, and stretching exercises.
28
Weight Control Nutritional Program
Group assigned to a Weight Control Nutritional Program (WC). Weight Control Nutritional Program: a week of food diary and information about dietary fat intake and proper proportions of vegetables.
27
Home-based Exercise Program
Group assigned to a Home-based exercise program (Ex). Home-based exercise program: 24 week home-based exercise program encompassed aerobic exercises, isometric and isotonic exercises, and stretching exercises.
30
Usual Care
Usual care and non-specific health information (C). No intervention.
25
Total110

Baseline characteristics

CharacteristicTotalUsual CareHome-based Exercise ProgramWeight Control Nutritional ProgramWeight Control Nutritional and Home-based Exercise Pro
36 Items Short Form Survey Instrument (SF-36v) Mental Scale50.1 score
STANDARD_DEVIATION 10.8
48.3 score
STANDARD_DEVIATION 11.5
48.2 score
STANDARD_DEVIATION 11.4
51.9 score
STANDARD_DEVIATION 9.8
52.1 score
STANDARD_DEVIATION 10.6
Age, Continuous67.9 years
STANDARD_DEVIATION 8.4
69.5 years
STANDARD_DEVIATION 8.5
65.8 years
STANDARD_DEVIATION 7.6
66.3 years
STANDARD_DEVIATION 7.3
70.3 years
STANDARD_DEVIATION 9.6
BMI at Baseline34.4 kg/m^2
STANDARD_DEVIATION 5.9
32.8 kg/m^2
STANDARD_DEVIATION 5.1
34.3 kg/m^2
STANDARD_DEVIATION 5.4
36.8 kg/m^2
STANDARD_DEVIATION 6.2
33.8 kg/m^2
STANDARD_DEVIATION 6.4
Duration of OA10.0 years
STANDARD_DEVIATION 10.1
10.0 years
STANDARD_DEVIATION 9.8
11.5 years
STANDARD_DEVIATION 13.2
9.4 years
STANDARD_DEVIATION 6
9.1 years
STANDARD_DEVIATION 10.4
Married
Married
67 participants16 participants20 participants18 participants13 participants
Married
Not-Married
43 participants9 participants10 participants9 participants15 participants
Race/Ethnicity, Customized
Non-white
11 participants1 participants2 participants4 participants4 participants
Race/Ethnicity, Customized
White
99 participants24 participants28 participants23 participants24 participants
Sex: Female, Male
Female
11 Participants1 Participants3 Participants2 Participants5 Participants
Sex: Female, Male
Male
99 Participants24 Participants27 Participants25 Participants23 Participants
SF-36v Physical Scale36.9 score
STANDARD_DEVIATION 8.3
36.4 score
STANDARD_DEVIATION 9
35.7 score
STANDARD_DEVIATION 8.2
41.1 score
STANDARD_DEVIATION 7.2
34.7 score
STANDARD_DEVIATION 7.8
Stair Total (climb, descend)176.0 stairs
STANDARD_DEVIATION 52.8
171.7 stairs
STANDARD_DEVIATION 52.8
182.9 stairs
STANDARD_DEVIATION 54.1
181.0 stairs
STANDARD_DEVIATION 53.2
167.7 stairs
STANDARD_DEVIATION 52.5
Walking Distance443.8 meters
STANDARD_DEVIATION 102.7
435.1 meters
STANDARD_DEVIATION 82.4
476.9 meters
STANDARD_DEVIATION 101.4
445.1 meters
STANDARD_DEVIATION 125.4
414.9 meters
STANDARD_DEVIATION 92.6
WOMAC Function41.9 Score
STANDARD_DEVIATION 12.2
44.4 Score
STANDARD_DEVIATION 14.8
40.3 Score
STANDARD_DEVIATION 10.6
39.2 Score
STANDARD_DEVIATION 12
44.0 Score
STANDARD_DEVIATION 11.4

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
6 / 283 / 277 / 306 / 25
serious
Total, serious adverse events
0 / 280 / 270 / 300 / 25

Outcome results

Primary

Mental Scale SF-36v

The Rand Short Form-36 (SF-36) was used to measure health related quality of life (i.e. mental health). The average change in score 24 weeks post-baseline was measured. Mental Health component consisted of 4 scales; these are the scales: Vitality ( 4 items), Social functioning (2 items), Role Emotional (3 items), and Mental Health (5 items). The mental health summary measures is called the Mental health component of SF36v. It was used to measure health related quality of life (i.e. mental health). The total score ranged from 0 to 100, a score of 50 is the normative average for general mental health. Lower scores correspond to worse mental health status, higher scores correspond to better mental health status.

Time frame: Between Base-line and 24 weeks

Population: There are discrepancies in the numbers of participants being analyzed due to incomplete data collection. the disprepancies are in the following groups: 1 in Weight control Nutritional and home -based Exercise program, 3 in Weight Control Nutritional Program and 3 in Usual Care

ArmMeasureValue (MEAN)
Weight Control Nutritional and Home-based Exercise ProMental Scale SF-36v0.28 Change in Score
Weight Control Nutritional ProgramMental Scale SF-36v2.62 Change in Score
Home-based Exercise ProgramMental Scale SF-36v-0.23 Change in Score
Usual CareMental Scale SF-36v-2.64 Change in Score
Primary

Physical Scale SF-36v

The Rand Short Form-36 (SF-36) was used to measure health related quality of life (i.e. physical health). The average change in score 24 weeks post-baseline was measured. Physical Health consists of 4 scales, Physical Function (10 items), Role Physical (4 items), Bodily Pain (2 items), General Health (5 items). The Physical Health component is a summary measure of scales, and the scores ranges from 0 to 100, a score of 50 is the normative average of general health. Lower scores correspond to worse physical health, higher scores correspond to better physical health.

Time frame: Between Base-line and 24 weeks

Population: There are discrepancies in the numbers of participants being analyzed due to incomplete data collection. the disprepancies are in the following groups: 1 in Weight control Nutritional and home -based Exercise program, 3 in Weight Control Nutritional Program, 3 in the Usual Care.

ArmMeasureValue (MEAN)
Weight Control Nutritional and Home-based Exercise ProPhysical Scale SF-36v5.51 Change in score
Weight Control Nutritional ProgramPhysical Scale SF-36v0.56 Change in score
Home-based Exercise ProgramPhysical Scale SF-36v3.58 Change in score
Usual CarePhysical Scale SF-36v0.34 Change in score
p-value: 0.030795% CI: [0.432, 8.659]ANCOVA
Primary

WOMAC Function

Western Ontario and McMaster University Osteoarthritis Index (WOMAC) is used to measure pain, function, and stiffness in patients with OA of the knee. At 24 weeks post-baseline, the average change in score was measured. We used the Function Scale only for this study. The Function Scale has 17 items, the responses are in Likert scale; namely 0=No difficulty, 1=Slight, 2=Moderate, 3= Very, 4=Extremely. The total score ranges from 0 to 68, a higher score means worse functioning. A score of 68 indicates extremely difficult in functioning.

Time frame: Between Base-line and 24 weeks

Population: There are discrepancies in the numbers of participants being analyzed due to incomplete data collection. the disprepancies are in the following groups: 2 in Weight control Nutritional and home -based Exercise program, 3 in Weight Control Nutritional Program, 1 in Home-based exercise program and 1 in Usual Care.

ArmMeasureValue (MEAN)
Weight Control Nutritional and Home-based Exercise ProWOMAC Function-10.4 Change in Score
Weight Control Nutritional ProgramWOMAC Function-4.8 Change in Score
Home-based Exercise ProgramWOMAC Function-4.9 Change in Score
Usual CareWOMAC Function-1.6 Change in Score
p-value: 0.012995% CI: [-11.41, -1.38]ANCOVA
p-value: 0.053595% CI: [-10.43, 0.079]ANCOVA
Secondary

Stair Total (Climb, Descend)

Total amount of stairs climbed and descended for three minutes. Subjects climbed four steps up and descended four steps down. The average change in total number of steps 24 weeks post-baseline was measured.

Time frame: Between Base-line and 24 Weeks

Population: There are discrepancies in the numbers of participants being analyzed due to incomplete data collection. the disprepancies are in the following groups: 2 in Weight control Nutritional and home -based Exercise program, 1 in Weight Control Nutritional Program, 1 in Home-based exercise Program and 1 in Usual Care.

ArmMeasureValue (MEAN)
Weight Control Nutritional and Home-based Exercise ProStair Total (Climb, Descend)39.75 Change in Steps
Weight Control Nutritional ProgramStair Total (Climb, Descend)23.61 Change in Steps
Home-based Exercise ProgramStair Total (Climb, Descend)40.48 Change in Steps
Usual CareStair Total (Climb, Descend)9.06 Change in Steps
p-value: 0.001895% CI: [10.767, 45.492]ANCOVA
p-value: 0.002495% CI: [9.675, 43.746]ANCOVA
p-value: 0.036895% CI: [1.169, 36.325]ANCOVA
Secondary

Walking Distance

Average distance walked in six minutes. The average change in distance walked (meters) 24 weeks post-baseline was measured.

Time frame: Between Base-line and 24 weeks

Population: There are discrepancies in the numbers of participants being analyzed due to incomplete data collection. the disprepancies are in the following groups: 1 in Weight control Nutritional and home -based Exercise program, 2 in Weight Control Nutritional Program.

ArmMeasureValue (MEAN)
Weight Control Nutritional and Home-based Exercise ProWalking Distance71.64 Change in Distance (m)
Weight Control Nutritional ProgramWalking Distance17.42 Change in Distance (m)
Home-based Exercise ProgramWalking Distance42.08 Change in Distance (m)
Usual CareWalking Distance6.55 Change in Distance (m)
p-value: 0.015895% CI: [7.655, 72.215]ANCOVA
p-value: 0.000295% CI: [29.97, 94.54]ANCOVA
p-value: 0.005695% CI: [12.54, 75.36]ANCOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026